5C6.F CLEARBRIDGE HEALTH LTD

Healthcare Biotechnology Frankfurt Exchange
0.0005 EUR
Close of Nov 11, 2026
0.0005 0.0010
Market cap
EUR 3.22M
P/E
-
P/B
0.70x
ROE
-374.5%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 5C6.F undervalued?

Graham number

The Graham number of CLEARBRIDGE HEALTH LTD cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

CLEARBRIDGE HEALTH LTD fundamental analysis

No fundamental analysis for CLEARBRIDGE HEALTH LTD yet.

CLEARBRIDGE HEALTH LTD stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About CLEARBRIDGE HEALTH LTD

Clearbridge Health Limited, an investment holding company, provides healthcare solutions in Singapore, the Philippines, Hong Kong, and internationally. It operates through Medical Clinics/Centres and Strategic Investments segments. The company provides imaging services, including general x-ray, computerized tomography scan, dental cone beam CT scan, mammography, magnetic resonance imaging, and ultrasound; general health services, such as diabetes, high blood pressure, and hi…

Full company profile